10-Q Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0001213900-22-046934`
Period End Date	20220630
Filing Date	20220811
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	f10q0622_relmadatherap_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 53 Income Statement 56 Cash Flow Statement 53 Stockholders Equity 33

Balance Sheet 53 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`Cash`	$37.26M	USD	Point-in-time
Cash and cash equivalents	`Cash`	$44.44M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$174.69M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$167.47M	USD	Point-in-time
Lease payments receivable short term	`LeasePaymentsReceivableShortTerm`	$42.23K	USD	Point-in-time
Lease payments receivable short term	`LeasePaymentsReceivableShortTerm`	$86.38K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$11.30M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$3.48M	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$256.19K	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$215.74M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$223.30M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$35.24K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$28.29K	USD	Point-in-time
Total assets	`Assets`	$215.77M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Total assets	`Assets`	$223.33M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Commitments and Contingencies (See Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Commitments and Contingencies (See Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$7.54M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.74M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$11.19M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.02M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.74M	shares	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$3.87M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$11.38M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.02M	shares	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.06M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.92M	USD	Point-in-time
Preferred stock, $0.001 par value, 200,000,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value, 200,000,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding	`PreferredStockValue1`	-	USD	Point-in-time
Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding	`PreferredStockValue1`	-	USD	Point-in-time
Common stock, $0.001 par value, 150,000,000 shares authorized, 30,024,594 and 27,740,147 shares issued and outstanding, respectively	`CommonStockValue`	$27.74K	USD	Point-in-time
Common stock, $0.001 par value, 150,000,000 shares authorized, 30,024,594 and 27,740,147 shares issued and outstanding, respectively	`CommonStockValue`	$30.02K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$581.57M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$513.30M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-305.07M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-384.75M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$196.85M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$208.26M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$223.33M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$215.77M	USD	Point-in-time

Income Statement 56 line items

Line Item	Tag	Value	Unit	Period
Loss per common share basic and diluted	`EarningsPerShareDiluted`	$-2.90	USD	2 Qtrs
Loss per common share basic and diluted	`EarningsPerShareDiluted`	$-1.33	USD	1 Quarter
Loss per common share basic and diluted	`EarningsPerShareDiluted`	$-1.56	USD	1 Quarter
Loss per common share basic and diluted	`EarningsPerShareDiluted`	$-2.73	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$17.33M	USD	1 Quarter
Weighted average number of common shares outstanding basic and diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	29.17M	shares	2 Qtrs
Weighted average number of common shares outstanding basic and diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	16.81M	shares	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$31.35M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$55.93M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$30.91M	USD	1 Quarter
Weighted average number of common shares outstanding basic and diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	29.94M	shares	1 Quarter
Weighted average number of common shares outstanding basic and diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	17.05M	shares	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$27.88M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$17.51M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$9.13M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$14.60M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$45.51M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$26.46M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$48.87M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$83.81M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-26.46M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-45.51M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-83.81M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-48.87M	USD	2 Qtrs
Gain on settlement of fees	`GainLossRelatedToLitigationSettlement`	$6.35M	USD	1 Quarter
Gain on settlement of fees	`GainLossRelatedToLitigationSettlement`	$6.35M	USD	2 Qtrs
Interest/investment income, net	`InterestIncomeExpenseNet`	$742.78K	USD	2 Qtrs
Interest/investment income, net	`InterestIncomeExpenseNet`	$387.33K	USD	1 Quarter
Interest/investment income, net	`InterestIncomeExpenseNet`	$717.28K	USD	2 Qtrs
Interest/investment income, net	`InterestIncomeExpenseNet`	$322.81K	USD	1 Quarter
Realized (loss) gain on short-term investments	`RealizedInvestmentGainsLosses`	$24.50K	USD	1 Quarter
Realized (loss) gain on short-term investments	`RealizedInvestmentGainsLosses`	$-176.38K	USD	2 Qtrs
Realized (loss) gain on short-term investments	`RealizedInvestmentGainsLosses`	$-123.59K	USD	1 Quarter
Realized (loss) gain on short-term investments	`RealizedInvestmentGainsLosses`	$9.48K	USD	2 Qtrs
Unrealized loss on short-term investments	`UnrealizedGainLossOnInvestments`	$-2.95M	USD	2 Qtrs
Unrealized loss on short-term investments	`UnrealizedGainLossOnInvestments`	$-1.19M	USD	1 Quarter
Unrealized loss on short-term investments	`UnrealizedGainLossOnInvestments`	$-466.44K	USD	2 Qtrs
Unrealized loss on short-term investments	`UnrealizedGainLossOnInvestments`	$-289.28K	USD	1 Quarter
Total other (expenses) income	`NonoperatingIncomeExpense`	$-90.06K	USD	1 Quarter
Total other (expenses) income	`NonoperatingIncomeExpense`	$99.96K	USD	2 Qtrs
Total other (expenses) income	`NonoperatingIncomeExpense`	$5.58M	USD	1 Quarter
Total other (expenses) income	`NonoperatingIncomeExpense`	$4.13M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-39.75M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.22M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-26.55M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-79.68M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-48.77M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-39.93M	USD	1 Quarter
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasic`	$-1.33	USD	1 Quarter
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasic`	$-2.73	USD	2 Qtrs
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasic`	$-1.56	USD	1 Quarter
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasic`	$-2.90	USD	2 Qtrs
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	29.17M	shares	2 Qtrs
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	16.81M	shares	2 Qtrs
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	29.94M	shares	1 Quarter
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	17.05M	shares	1 Quarter

Cash Flow Statement 53 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-39.75M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.22M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-26.55M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-79.68M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-48.77M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-39.93M	USD	1 Quarter
Depreciation expense	`Depreciation`	$1.26K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$24.23M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$14.12M	USD	2 Qtrs
Gain on settlement of fees	`GainLossRelatedToLitigationSettlement`	$6.35M	USD	1 Quarter
Gain on settlement of fees	`GainLossRelatedToLitigationSettlement`	$6.35M	USD	2 Qtrs
Realized loss (gain) on short-term investments	`IncomeLossFromEquityMethodInvestments`	$9.48K	USD	2 Qtrs
Realized loss (gain) on short-term investments	`IncomeLossFromEquityMethodInvestments`	$-176.38K	USD	2 Qtrs
Unrealized loss on short-term investments	`UnrealizedlossGainOnShorttermInvestments`	$-466.44K	USD	2 Qtrs
Unrealized loss on short-term investments	`UnrealizedlossGainOnShorttermInvestments`	$-2.95M	USD	2 Qtrs
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-44.14K	USD	2 Qtrs
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-38.90K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$256.19K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpense`	$645.69K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpense`	$-7.81M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.11M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.70M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$7.51M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-796.16K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-41.06M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-33.30M	USD	2 Qtrs
Purchase of short-term investments	`PaymentsToAcquireInvestments`	$33.41M	USD	2 Qtrs
Purchase of short-term investments	`PaymentsToAcquireInvestments`	$56.87M	USD	2 Qtrs
Sale of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$66.43M	USD	2 Qtrs
Sale of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$23.24M	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$9.55M	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-10.17M	USD	2 Qtrs
Proceeds from issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$23.46M	USD	2 Qtrs
Proceeds from issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$42.73M	USD	2 Qtrs
Proceeds from options exercised for common stock	`ProceedsFromOptionsExercisedForCommonStock`	$417.54K	USD	2 Qtrs
Proceeds from options exercised for common stock	`ProceedsFromOptionsExercisedForCommonStock`	$517.27K	USD	2 Qtrs
Proceeds from warrants exercised for common stock	`CashlessEexerciseOfWarrants`	$-895.36K	USD	2 Qtrs
Proceeds from warrants exercised for common stock	`CashlessEexerciseOfWarrants`	$-1.94M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$44.04M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$25.92M	USD	2 Qtrs
Net (decrease)/increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-7.18M	USD	2 Qtrs
Net (decrease)/increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$2.17M	USD	2 Qtrs
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.50M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$44.44M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$37.26M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$4.67M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.50M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$44.44M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$37.26M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$4.67M	USD	Point-in-time
Interest	`InterestPaidNet`	-	USD	2 Qtrs
Income Tax	`IncomeTaxesPaidNet`	-	USD	2 Qtrs
Income Tax	`IncomeTaxesPaidNet`	-	USD	2 Qtrs

Stockholders Equity 33 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$210.40M	USD	Point-in-time
Balance	`StockholdersEquity`	$105.58M	USD	Point-in-time
Balance	`StockholdersEquity`	$196.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$208.26M	USD	Point-in-time
Balance	`StockholdersEquity`	$96.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$91.15M	USD	Point-in-time
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$12.30M	USD	5 Qtrs
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$8.27M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$11.93M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$5.85M	USD	1 Quarter
ATM offering, net	`ProceedsFromIssuanceInitialPublicOffering`	$29.58M	USD	1 Quarter
ATM offering, net	`ProceedsFromIssuanceInitialPublicOffering`	$23.46M	USD	1 Quarter
ATM offering, net	`ProceedsFromIssuanceInitialPublicOffering`	$13.15M	USD	1 Quarter
Warrant exercised for cash	`WarrantExercisedForCash`	$1.46M	USD	1 Quarter
Warrant exercised for cash	`WarrantExercisedForCash`	$300.01K	USD	1 Quarter
Warrant exercised for cash	`WarrantExercisedForCash`	$595.35K	USD	5 Qtrs
Warrant exercised for cash	`WarrantExercisedForCash`	$481.45K	USD	1 Quarter
Cashless option exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$352.74K	USD	1 Quarter
Options exercised for cash	`OptionExercisedForCash`	$467.77K	USD	1 Quarter
Options exercised for cash	`OptionExercisedForCash`	$64.80K	USD	1 Quarter
Options exercised for cash	`OptionExercisedForCash`	$49.50K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.75M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.22M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-26.55M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-79.68M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-48.77M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-39.93M	USD	1 Quarter
Balance	`StockholdersEquity`	$210.40M	USD	Point-in-time
Balance	`StockholdersEquity`	$105.58M	USD	Point-in-time
Balance	`StockholdersEquity`	$196.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$208.26M	USD	Point-in-time
Balance	`StockholdersEquity`	$96.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$91.15M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.